Replies to post #359067 on Amarin Corp Plc (AMRN)

[Invest83838]

Great Job Amarin Management

You deserve more free shares

NOT!

[studythosestocks]

Very upsetting.

[roadkilll]

Pfizer please
Pfizer marketing and legal arm needed to go after the mineral oil and DHA being the "excuse" for the impressive REDUCE-IT results. The recent revival of the old news proven wrong has gotten a second life in actual medical journals. Docs often just read headlines and are influenced as many are too busy to go a little deeper on these ignorant articles.

Amarin? They can't get Amazon Pharmacy from dispensing Vascepa with misbranded info that leaves out the primary patent for CV protection. A federal offense.

Docs going back to fish oil for cardio protective add on. Sad. The misinformation needs to be a focus for lawsuits. Doctors need to see retractions in the medical journals.

Pfizer is needed soon.

[dmiller]

Hey but don't worry, Amarin has most of the manufacturing supply locked up. The generics can't do vey much damage. Oopsie! As far as the insurance co's go, I tried telling you a long time ago that they started to stop covering Vascepa. I see some people are just waking up to this fact.

[rafunrafun]

Scripts for week ending November 5, 2021

Overall drug TRx +0.2% w/w

Vascepa
TRx 79,838; +2.9% (+2,223) w/w; -15.4% y/y
NRx 35,526; +2.0% (+686) w/w; -17.3% y/y
Ref 44,312; +3.6% (+1,537) w/w; -13.7% y/y

Lovaza (Generic & Brand)
TRx 62,581; +0.2% (+110) w/w; -1.9% y/y
NRx 30,555; +0.3% (+105) w/w; -7.9% y/y
Ref 32,026; +0.0% (+5) w/w; +4.5% y/y

Generic Vascepa
TRx 21,148; -0.0% (-1) w/w; As % of total V: 20.9%
NRx 12,021; -0.8% (-94) w/w; As % of total V: 25.3%
Ref 9,127; +1.0% (+93) w/w; As % of total V: 17.1%

Generic Vascepa by Manufacturer
Hikma - TRx 12,496 (-59); Generic share 59.1%; Total V share 12.4%
Reddy - TRx 8,652 (+58); Generic share 40.9%; Total V share 8.6%

TRx Vascepa + Generic Vascepa
TRx 100,886; +2.2% (+2,222)
NRx 47,548; +1.3% (+592)
Ref 53,439; +3.1% (+1,630)